Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between the TIMD4-HAVCR1 variants and serum lipid levels, coronary heart disease and ischemic stroke risk and atorvastatin lipid-lowering efficacy.

Bioscience reports - 28 Feb 2018

Zhang Qing-Hui, Yin Rui-Xing, Chen Wu-Xian, Cao Xiao-Li, Chen Yu-Ming

Abstract excerpt

Little is known about the association of the TIMD4 (T-cell immunoglobulin and mucin domain 4 gene)-HAVCR1 (hepatitis A virus cellular receptor 1) variants and lipid metabolism, the risk of coronary heart disease (CHD) and ischemic stroke (IS). The present study aimed to determine the TIMD4-HAVCR1 variants, their haplotypes and gene-environment interactions on serum lipid levels, the risk of CHD and IS, and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atorvastatin
Share to Brain Ischemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol, HDL

Share to Cholesterol, LDL

Share to Coronary Disease

Share to Lipids

Share to Stroke

Share to Triglycerides

Source

Open in PubMed Open full text

Identifiers

PMID: 29208769
DOI: 10.1042/BSR20171058
PMCID: PMC5773822

Genes

HAVCR1
TIMD4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between the TIMD4-HAVCR1 variants and serum lipid levels, coronary heart disease and ischemic stroke risk and atorvastatin lipid-lowering efficacy.PMID 29208769Read ↗

Association of HMGCR rs17671591 and rs3761740 with lipidemia and statin response in Uyghurs and Han Chinese.Semantic proximity Read ↗

MADD-FOLH1 Polymorphisms and Their Haplotypes with Serum Lipid Levels and the Risk of Coronary Heart Disease and Ischemic Stroke in a Chinese Han Population.Semantic proximity Read ↗

Gene Polymorphisms Affect the Effectiveness of Atorvastatin in Treating Ischemic Stroke Patients.Semantic proximity Read ↗

Polymorphisms in CYP450 Genes and the Therapeutic Effect of Atorvastatin on Ischemic Stroke: A Retrospective Cohort Study in Chinese Population.Semantic proximity Read ↗

MassARRAY multigene screening combined with LDL-C and sdLDL-C detection for more favorable outcomes in type 2 diabetes mellitus therapySemantic proximity Read ↗

Genetic variants influencing lipid levels and risk of dyslipidemia in Chinese population.Semantic proximity Read ↗

CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin.Semantic proximity Read ↗

Associations of Two Common Polymorphisms in MTHFR Gene with Blood Lipids and Therapeutic Efficacy of Simvastatin.Semantic proximity Read ↗

Association of genetic loci with blood lipids in the Chinese population.Semantic proximity Read ↗

Genetic Polymorphisms, LDL-C and sdLDL-C Help Optimize Coronary Heart Disease (CHD) TherapySemantic proximity Read ↗

DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke.Semantic proximity Read ↗

The effect ofMVK-MMABvariants, their haplotypes and G×E interactions on serum lipid levels and the risk of coronary heart disease and ischemic strokeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.